Inventor
CHEN MAN
CN20 patents
⚠️ This page may combine multiple inventors who share the name “CHEN MAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
8 patentsUS10017543B2Jul 10, 2018
Prefusion RSV F proteins and their use
US HEALTH26 citations92
US9738689B2Aug 22, 2017
Prefusion RSV F proteins and their use
US HEALTH19 citations92
US11878998B2Jan 23, 2024
Prefusion RSV F proteins and their use
US HEALTH2 citations71
US11174292B2Nov 16, 2021
Substitutions-modified prefusion RSV F proteins and their use
US HEALTH2 citations71
US11130785B2Sep 28, 2021
Prefusion RSV F proteins and their use
US HEALTH2 citations71
US11981707B2May 14, 2024
Prefusion RSV F proteins and their use
US HEALTH0 citations61
US12275758B2Apr 15, 2025
Prefusion RSV F proteins and their use
US HEALTH0 citations60
US10858400B2Dec 8, 2020
Prefusion RSV F proteins and their use
US HEALTH0 citations51
CSG POWER GENERATION CO LTD
4 patentsUS11761859B2Sep 19, 2023
Method for self-adaption faster-than-real-time working condition start-up state prediction and estimation of unit
CSG POWER GENERATION CO LTD2 citations66
US11972557B2Apr 30, 2024
Vibration object monitoring method and apparatus, computer device and storage medium
CSG POWER GENERATION CO LTD1 citations55
US12347295B2Jul 1, 2025
Method and device for smoke or fire recognition, computer apparatus, and storage medium
CSG POWER GENERATION CO LTD0 citations44
US12158741B2Dec 3, 2024
Self-adaptive test method for intelligent prediction algorithm of analog measured values
CSG POWER GENERATION CO LTD0 citations44
SYNARC RES LABORATORY BEIJING LTD
3 patentsUS12492980B2Dec 9, 2025
Antibody combination for one-step screening and/or diagnosis of clonal diseases and related application
SYNARC RES LABORATORY BEIJING LTD0 citations42
US12146881B2Nov 19, 2024
Reagent composition for detection of non-hematopoietic tumor and use thereof
SYNARC RES LABORATORY BEIJING LTD0 citations42
US11953500B2Apr 9, 2024
Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application
SYNARC RES LABORATORY BEIJING LTD0 citations42